Post-doctoral position
INSERM/Aix-Marseille University
Ahmad Joshkon, PhD in Oncology, INSERM1263, INRAE1260, C2VN, Aix-Marseille University, France.
Primary focusing on deciphering the mecahanism of resistance to anti-angiogenic therapies in high-grade gliomas and in developing novel treatments including bispecific antibodies to combat this phenomenon but also to target and hamper cancer-associated thrombotic events.
Key words: Targeted therapy, Resistant tumors, Metastasis, Therapeutic antibodies, Cancer-associated thrombosis, Biomarker
Monday, July 11, 2022
11:45 AM – 12:00 PM